Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency ’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

FDA is taking new steps to strengthen agency ’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products
Source: Food and Drug Administration - Category: American Health Source Type: news